Informed consent |
○ |
|
|
|
|
|
Subject background |
○ |
|
|
|
|
|
Concomitant drugs |
○ |
○ |
|
|
|
|
Visual acuity test |
○ |
○ |
|
|
|
|
Treatment compliance |
|
○ |
|
|
|
|
Slit-lamp microscopy |
○ |
○ |
✓ |
|
|
Observation of the corneal epithelium |
Anterior-segment pictures (fluorescein staining) (BUT) |
○ |
○ |
✓ |
|
|
Evaluation of the influence on the corneal epithelium |
Specular microscope |
○ |
○ |
|
|
✓ |
Observation of the corneal endothelium. Measurement of endothelial cell density, and coefficient of variation (CV) |
DR-1 (BUT) |
○ |
○ |
✓ |
|
|
Evaluation of influence on the corneal epithelium based on tear film Iipid layer grading |
Schirmer l test (BUT) |
○ |
○ |
✓ |
|
|
Lacrimation function based on tear volume |
Pentacarn (Corneal thickness) |
○ |
○ |
|
✓ |
|
Measurement of corneal thickness (influence on the corneal endothelium) |
HRT II-RCM |
○ |
○ |
|
✓ |
|
Morphological observation of the corneal stroma Evaluation of cell density |
Adverse events |
○ |
○ |
|
|
|
|
Questionnaire to assess satisfaction with use |
|
○ |
|
|
|
Assessment of irritating sensation and drop comfort upon instillation using a VAS |